Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Net Cash Flow (2016 - 2025)

Veracyte's Net Cash Flow history spans 14 years, with the latest figure at $47.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 237.73% year-over-year to $47.0 million; the TTM value through Dec 2025 reached $122.9 million, up 417.92%, while the annual FY2025 figure was $122.9 million, 417.92% up from the prior year.
  • Net Cash Flow for Q4 2025 was $47.0 million at Veracyte, down from $96.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $96.0 million in Q3 2025 and bottomed at -$163.6 million in Q3 2021.
  • The 5-year median for Net Cash Flow is $10.2 million (2021), against an average of $795350.0.
  • The largest annual shift saw Net Cash Flow skyrocketed 352.74% in 2023 before it tumbled 661.51% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $9.0 million in 2021, then tumbled by 284.33% to -$16.6 million in 2022, then surged by 182.55% to $13.7 million in 2023, then crashed by 349.1% to -$34.1 million in 2024, then skyrocketed by 237.73% to $47.0 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Net Cash Flow are $47.0 million (Q4 2025), $96.0 million (Q3 2025), and $32.8 million (Q2 2025).